Machine Learning Pipeline Discovers 10 Potent Antimicrobial Peptides Against Pseudomonas aeruginosa

The escalating global health crisis of antibiotic resistance necessitates urgent novel antibacterial strategies. Traditional antibiotic development is slow, and existing drugs face increasing ineffectiveness against resilient pathogens like Pseudomonas aeruginosa. Antimicrobial peptides (AMPs) offer a promising alternative due to their broad-spectrum activity and lower propensity for resistance development, often targeting bacterial membranes. However, conventional AMP discovery methods are time-consuming and inefficient for screening the vast chemical space of potential peptide sequences, creating a significant bottleneck in therapeutic innovation.

Researchers developed an integrated prediction framework combining deep learning with classical machine learning to rapidly identify antimicrobial peptides. This model was applied to screen over 250,000 artificially generated peptide sequences. Candidate peptides were selected based on physicochemical descriptors and activity-associated features, followed by solid-phase synthesis. Their antibacterial efficacy was then experimentally validated using minimum inhibitory concentration (MIC) assays against Pseudomonas aeruginosa. Mechanistic investigations included scanning electron microscopy to visualize membrane damage, molecular dynamics simulations to probe peptide-membrane interactions, and transcriptomic profiling to assess bacterial stress responses and metabolic pathway alterations.

The integrated machine learning pipeline successfully identified Ten promising antibacterial candidates, all of which were experimentally validated. All selected peptides exhibited measurable activity against P. aeruginosa, with several demonstrating potent inhibitory effects. Microscopic and simulation analyses consistently confirmed that these peptides exert their antibacterial effects primarily through direct membrane disruption. This mechanism involves physical damage to the bacterial cell wall, compromising its integrity. Transcriptomic data further elucidated the peptides' impact, revealing significant interference with key bacterial metabolic pathways and the activation of various bacterial stress response systems. This multi-pronged attack underscores their potential efficacy. > The study successfully identified and validated 10 novel antimicrobial peptides, demonstrating potent activity against P. aeruginosa primarily via membrane disruption.